AEM vs CMP

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Compass Minerals presents a stark dichotomy between strong top-line growth and deteriorating fundamental health. The Piotroski F-Score of 2/9 indicates severe financial weakness, compounded by a high Debt/Equity ratio of 3.44. While the 1-year price performance is impressive (+103.1%) and the PEG ratio (0.12) suggests significant undervaluation relative to growth, the negative profit margins and poor historical earnings stability create a high-risk profile. The stock is currently trading near its analyst target price, leaving little room for immediate upside without a fundamental turnaround.